Clinical Trial: The S.A.F.E. Study : Computer-Aided Counseling to Prevent Teen Pregnancy/STDs
This study is currently recruiting patients.
Verified by University of Pittsburgh September 2005
| Sponsors and Collaborators: | University of Pittsburgh National Institute of Child Health and Human Development (NICHD) | | Information provided by: | University of Pittsburgh | | ClinicalTrials.gov Identifier: | NCT00151151 | |
Purpose
This is a
randomized clinical trial assessing the
efficacy of two types of counseling (Computer-Assisted Motivational
Intervention (CAMI) versus Didactic Educational Counseling (DEC)) to see which can better reduce female adolescents'''' risk taking behaviors that put them at risk for unintended pregnancy and sexually transmitted diseases (STDs). The
intervention phase consists of three 30-minute counseling sessions over the first 6 months followed by a visit every three months during the 12 month
follow up phase. We hypothesize that the CAMI will decrease the proportion of subjects who engage in any intercourse that is poorly protected against pregnancy and against STDs.
| Condition | Intervention |
Pregnancy Sexually Transmitted Diseases
| Behavior: Computer-Assisted Motivational Intervention Behavior: Didactic Educational Counseling
|
MedlinePlus related topics: Sexually Transmitted Diseases
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: The S.A.F.E. Study: Computer-Aided Counseling to Prevent Teen Pregnancy/STDs - Validity and Reliability Testing of Computer Measures, Pilot-Testing of Timeline Followback Calendar Protocol, and Randomized Efficacy Study
Further Study Details:
Primary Outcomes: Self-reported sexual and contraceptive behaviors recorded by a 90-day timeline follow back interview at 9 and 18 months compared to baseline
Secondary Outcomes: Stage of readiness to be abstinent, use condoms, spermicide, and hormonal contraception based on a computerized assessment; reported
drug and alcohol use recorded by a 90-day timeline follow back interview
Expected Total Enrollment: 660
Study start: February 2003; Expected completion: September 2007
Last follow-up: January 2007; Data entry closure: March 2007
Adolescent unintended pregnancy and STDs remain at epidemic levels in the United States. Healthy People 2010 Objectives set a goal to increase to 90% the proportion of sexually active adolescents who use contraception that both effectively prevents pregnancy and provides barrier protection against disease. How to effectively counsel adolescents to reach this goal is unclear. Counseling and feedback based on the Transtheoretical Model (TTM) have demonstrated greater success than standard, action-oriented advice in several domains of behavior change. The effectiveness of this type of counseling to alter female adolescents'''' sexual and contraceptive behaviors has not been rigorously evaluated. We propose recruiting 660 female adolescents, ages 13 to 21 years, from an inner-city, hospital-based clinic and randomizing them to either an innovative Computer-Assisted Motivational
Intervention (CAMI) or a Didactic Educational Control (DEC). The CAMI group will receive three, 30-minute sessions of one-on-one counseling with a counselor that is guided by computer-generated personalized feedback. The CAMI is based on the principles of the TTM and on Motivational Interviewing. The DEC provides three 30-minute sessions of one-on-one didactic information on contraception, STD prevention, and abstinence. The two interventions are identical in length and timing but vary in educational content, counseling style, and the provision of personalized feedback. We will track the two groups of female adolescents in this study through a 6-month
intervention phase and a 12-month
follow-up phase to assess differences in sexual and contraceptive behaviors by group. The primary specific aim for the study is to evaluate the
efficacy of the CAMI as compared to the DEC in reducing sexual behaviors that increase the risks of both unintended pregnancy and STDs. We will examine protective sexual behaviors in three ways: 1) behaviors that protect against pregnancy; 2) behaviors that protect against STDs; and 3) behaviors that protect against both pregnancy and STDs. Our primary
hypothesis is that the CAMI will decrease the proportion of subjects who engage in any intercourse that is poorly protected against pregnancy and against STDs. We also predict that among sexually active subjects, the CAMI will increase the percentage of episodes of intercourse that are well protected by the use of both condoms plus another contraceptive. Finally, we also predict that the CAMI will increase the prevalence of abstinence among the entire sample. If proven effective, computer-assisted personalized motivational counseling could be broadly implemented as a method to decrease the
incidence of unintended pregnancy and STDs among female adolescents.
Eligibility
Ages Eligible for Study: 13 Years - 21 Years, Genders Eligible for Study: Female
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Female adolescents, ages 13 to 21 years of age, not currently pregnant or planning pregnancy in next 18 months, English speaking, able to return every 3 months to study office for 18 months
Exclusion Criteria:
- Medically or surgically sterile, has IUD or subdermal contraceptive implant, hearing or visual impairments that might interfere with using the computerized assessment or participating in counseling session, in foster care or on house arrest, has sex exclusively with female partners
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00151151
Melanie A. Gold, DO 412 -692-8504 magold@pitt.edu
Rita L. Labbett, BA 412-692-6829 Rita.Labbett@chp.edu
Pennsylvania Children''''s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States; Recruiting
Rita L. Labbett, BA 412-692-6829 Rita.Labbett@chp.edu
Melanie A. Gold, DO 412-692-8504 magold@pitt.edu
Melanie A. Gold, DO, Principal Investigator
Study chairs or principal investigators
Melanie A. Gold, DO, Principal Investigator, University of Pittsburgh
More Information
Study ID Numbers: 0405473; HD41058
Last Updated: September 7, 2005
Record first received: September 6, 2005
ClinicalTrials.gov Identifier: NCT00151151
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13
Source: ClinicalTrials.gov
Cache Date: September 14, 2005